ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS

Test, Natriuretic Peptide

BAYER HEALTHCARE, LLC

The following data is part of a premarket notification filed by Bayer Healthcare, Llc with the FDA for Acs:180 And Advia Centaur B-type Natriuretic Peptide (bnp) Assays.

Pre-market Notification Details

Device IDK043228
510k NumberK043228
Device Name:ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS
ClassificationTest, Natriuretic Peptide
Applicant BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
ContactCarol Bianca
CorrespondentCarol Bianca
BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
Product CodeNBC  
CFR Regulation Number862.1117 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-11-22
Decision Date2005-04-22
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.